Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction
Author(s) -
Lorenz Räber,
Henning Kelbæk,
Miodrag Ostojić,
Andreas Baumbach,
Dik Heg,
David Tüller,
Clemens von Birgelen,
Marco Roffi,
Aris Moschovitis,
Ahmed A. Khattab,
Peter Wenaweser,
Robert F. Bonvini,
Giovanni Pedrazzini,
Ran Kornowski,
Klaus Weber,
Sven Trelle,
Thomas F. Lüscher,
Masanori Taniwaki,
Christian M. Matter,
Bernhard Meier,
Peter Jüni,
Stephan Windecker,
for the COMFORTABLE AMI Trial Investigators
Publication year - 2012
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2012.10065
Subject(s) - medicine , percutaneous coronary intervention , myocardial infarction , conventional pci , cardiology , hazard ratio , stent , bare metal , target lesion , revascularization , clinical endpoint , bare metal stent , randomized controlled trial , surgery , drug eluting stent , restenosis , confidence interval
The efficacy and safety of drug-eluting stents compared with bare-metal stents remains controversial in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom